
The nominee for the position of South Korea’s antitrust chief apologized on Monday, July 4th, over allegations he sexually harassed students while teaching at Seoul National University School of Law.
Song Ok-rial issued the apology through the presidential office shortly after he was nominated by President Yoon Suk-yeol to lead the Fair Trade Commission.
The Seoul Economic Daily newspaper reported the allegations earlier, saying Song told a group of freshmen while drunk during a dinner in 2014 that their looks ranked “better than average,” “worse than average,” or “high.”
Read More: South Korea Ads 34 More Firms To Antitrust Watchlist
The students who witnessed Song’s actions considered making a poster denouncing him, but the professor immediately apologized and reached an agreement with them not to take the issue further, the paper said.
“In the vetting process, we verified the circumstances surrounding his remarks and the detailed story,” the presidential office said in a statement. “The nominee apologized to the attendees at the time, and we took into consideration the fact that the matter was settled without further action by the school.”
The office added: “Nominee Song has admitted his mistake and said he apologizes deeply once again. A more detailed explanation is expected to be provided once a confirmation preparation team is set up by the Fair Trade Commission.”
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Fortnite Returns to Apple’s U.S. App Store After Five-Year Ban
May 21, 2025 by
CPI
Federal Court to Hear Case on Trump’s Firing of FTC Democrats
May 20, 2025 by
CPI
UK Government Suffers Third Successive Defeat on Data (Use and Access) Bill
May 20, 2025 by
CPI
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas